Key facts
- It has raised $82.3M; the latest was Later Stage VC in Sep 2024.
- Notable investors include New Alliance Capital, CPE Funds Management, Global Support Capital, BRM Group, Arbelon Holdings — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Rapid Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Rapid Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rapid Medical
Developer of interventional endovascular devices designed to focus on ischemic and hemorrhagic stroke. The company utilizes proprietary manufacturing techniques, which consist of a controllable, fully visible retriever that treats ischemic stroke patients and also consists of a controllable aneurysm neck-bridging device that helps physicians to respond in real-time to the anatomy and tailor the approach to every patient for better procedural outcomes, enabling patients to receive treatment for peripheral arterial disease.
- Sector
- Healthcare
- HQ
- Yokneam, Israel
- Founded
- 2008
- Employees
- 147
- Website
- rapid-medical.com/
- Ownership
- Privately Held (backing)
Rapid Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rapid Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rapid Medical in its N-PORT filings yet. We sweep new filings monthly.